跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,889 条关于
“EXPD-101”
全部
11,889
临床试验
4,960
药物
5,129
机构
22
资讯
1,778
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
11个月前
Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD
上个月
Expedition Therapeutics Raises $115M Series B to Advance First Global Phase 2 Trial of DPP1 Inhibitor in COPD
去年
Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials
去年
Galimedix Therapeutics Initiates Phase 2 Trial of GAL-101 Eye Drops for Dry AMD
2年前
FDA Clears IND for Arbor Biotechnologies' ABO-101 Gene-Editing Therapy for Primary Hyperoxaluria Type 1
去年
Siren Biotechnology's SRN-101 Receives FDA Designations for High-Grade Gliomas
去年
Beckley Psytech Announces Positive Results for ELE-101 in Depression Trial
去年
MAIA Biotechnology's THIO-101 Shows Promise in Advanced NSCLC
去年
TTI-101 Shows Promise in Advanced Cancer Treatment by Targeting STAT3
第 1 页,共 178 页
上一页
下一页